Pricing
  1. US-listed companies
  2. Avid Bioservices, Inc.
  3. Financials
  4. Revenue growth (%)

Avid Bioservices, Inc. (CDMO)

Market cap
$798.9M
P/E ratio
SummaryFinancials
Period EndRevenue growth (%) YoY (%)
Apr 30, 2024-6.3-125.27%
Apr 30, 202324.8+0.24%
Apr 30, 202224.8-59.14%
Apr 30, 202160.6+432.34%
Apr 30, 202011.4-38033.33%
Apr 30, 2019-0-99.57%
Apr 30, 2018-7-124.02%
Apr 30, 201729-56.67%
Apr 30, 201666.9+241.99%
Apr 30, 201519.6+490.63%
Apr 30, 20143.3-92.18%
Apr 30, 201342.3

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat